Healthcare -
Biotechnology - NASDAQ - US
$ 54.8
-1.03 %
$ 6.97 B
Market Cap
18.15
P/E
HALO - DEFERRED INCOME TAX
Deferred Income Tax HALO - Halozyme Therapeutics, Inc.
34.5 M
LAST VALUE
49.06%
2 YEAR CAGR
67.50%
5 YEAR CAGR
40.94%
10 YEAR CAGR